Sign Up to like & get
recommendations!
0
Published in 2017 at "Oncotarget"
DOI: 10.18632/oncotarget.19367
Abstract: Hepatocellular carcinoma (HCC) is one of the most common malignancies worldwide with limited therapeutic options. Here we report the development of a therapeutic vaccination regimen (shortened as 'TheraVac') consisting of intratumoral delivery of high-mobility group…
read more here.
Keywords:
hepa1;
large mouse;
therapeutic vaccine;
cure large ... See more keywords